We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Combo Product Makers: Anticipate Postapproval Changes
FDA to Combo Product Makers: Anticipate Postapproval Changes
January 18, 2013
Makers of drug-device combination products are urged to anticipate postapproval changes they may wish to make and develop protocols for preparing modification proposals, new FDA draft guidance states.